Impact of generic market entry on the consumption of last-resort antibiotics in six European countries
Abstract
OBJECTIVES: Excessive antibiotic use drives antimicrobial resistance. Patent expiry and subsequent generic market entry (GME) are suggested to alter antibiotic consumption, but evidence is limited. We examined GME impact on the use of selected antibiotics, including WHO 'Reserve' agents, in six European countries.
METHODS: We conducted a retrospective multicountry analysis using IQVIA MIDAS data (hospital and retail consumption panels: Austria, France, Germany, Italy, Spain; Hospital consumption only: Belgium) from 2012 to 2021. Substances included daptomycin, linezolid, tigecycline, teicoplanin, and moxifloxacin. GME was defined in each country as the time of the first consumption of non-originator products. Hospital consumption was expressed in defined daily doses (DDDs) per 1000 discharges. Associations between GME and antibiotic use were assessed through segmented linear regression modelling.
RESULTS: The impact of GME varied by antibiotic, country, and sector. Hospital consumption of daptomycin increased significantly following GME in all countries, with median rates from 8.8 to 63.9 DDD/1000 discharges. Linezolid use rose significantly in 4 countries, with rates between 24.7 and 110.4 DDD/1000 discharges. Tigecycline and teicoplanin showed heterogeneous patterns. By contrast, hospital and retail consumption of moxifloxacin showed predominantly decreasing trends, although not consistently significant, with marked country variation.
CONCLUSIONS: GME did not consistently…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.